• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?

作者信息

Somay Efsun

机构信息

Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, 82. Street No: 26, Bahcelievler, Ankara, Turkey.

出版信息

Osteoporos Int. 2023 Oct;34(10):1811-1812. doi: 10.1007/s00198-023-06821-8. Epub 2023 Jul 7.

DOI:10.1007/s00198-023-06821-8
PMID:37418153
Abstract
摘要

相似文献

1
Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?评论：一项关于接受口服双膦酸盐治疗的患者拔牙后与药物性颌骨坏死相关危险因素的多中心回顾性研究：一期伤口缝合和药物假期真的能预防药物性颌骨坏死吗？
Osteoporos Int. 2023 Oct;34(10):1811-1812. doi: 10.1007/s00198-023-06821-8. Epub 2023 Jul 7.
2
A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?一项多中心回顾性研究，探讨了接受口服双膦酸盐治疗的拔牙后药物相关性颌骨坏死的相关风险因素：原发伤口闭合和药物暂停真的能预防 MRONJ 吗？
Osteoporos Int. 2017 Aug;28(8):2465-2473. doi: 10.1007/s00198-017-4063-7. Epub 2017 Apr 27.
3
Author response to OSIN-D-23-00510, "Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?".作者对OSIN-D-23-00510的回复，“对《接受口服双膦酸盐治疗的患者拔牙后与药物性颌骨坏死相关危险因素的多中心回顾性研究：一期伤口缝合和药物假期真的能预防药物性颌骨坏死吗？》的评论”
Osteoporos Int. 2023 Oct;34(10):1809. doi: 10.1007/s00198-023-06835-2. Epub 2023 Jul 7.
4
Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study.癌症患者拔牙后与药物相关的颌骨坏死：一项多中心回顾性研究。
Osteoporos Int. 2019 Jan;30(1):231-239. doi: 10.1007/s00198-018-4746-8. Epub 2018 Nov 7.
5
Interventions for managing medication-related osteonecrosis of the jaw.颌骨药物相关性骨坏死的管理干预措施。
Cochrane Database Syst Rev. 2017 Oct 6;10(10):CD012432. doi: 10.1002/14651858.CD012432.pub2.
6
Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study.拔牙后地舒单抗相关性颌骨坏死和癌症患者短期停药的影响：一项多中心回顾性研究。
Osteoporos Int. 2021 Nov;32(11):2323-2333. doi: 10.1007/s00198-021-05995-3. Epub 2021 May 17.
7
Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?影响接受大剂量双膦酸盐或地舒单抗治疗的癌症患者药物相关性颌骨坏死发展的因素：拔牙是否为危险因素？
PLoS One. 2018 Jul 26;13(7):e0201343. doi: 10.1371/journal.pone.0201343. eCollection 2018.
8
Treatment of Medication-Related Osteonecrosis of the Jaw: Controversies in Causality and Therapy.治疗药物相关性颌骨坏死：病因和治疗的争议。
Dent Clin North Am. 2024 Jan;68(1):67-85. doi: 10.1016/j.cden.2023.07.005. Epub 2023 Aug 30.
9
Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.拔牙后进行一期伤口缝合以预防接受地诺单抗治疗患者的药物相关性颌骨坏死
Clin Oral Investig. 2017 Jan;21(1):127-134. doi: 10.1007/s00784-016-1762-y. Epub 2016 Feb 29.
10
Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study.长期口服双膦酸盐会延迟拔牙后愈合：单机构前瞻性研究。
Osteoporos Int. 2018 Oct;29(10):2315-2321. doi: 10.1007/s00198-018-4621-7. Epub 2018 Jul 2.

本文引用的文献

1
American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update.美国口腔颌面外科学会关于药物相关性颌骨坏死的立场文件-2022 更新。
J Oral Maxillofac Surg. 2022 May;80(5):920-943. doi: 10.1016/j.joms.2022.02.008. Epub 2022 Feb 21.
2
Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020.药物相关性颌骨坏死 (MRONJ) 的预防和诊断：意大利 2020 年共识更新。
Int J Environ Res Public Health. 2020 Aug 18;17(16):5998. doi: 10.3390/ijerph17165998.
3
A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
一项多中心回顾性研究，探讨了接受口服双膦酸盐治疗的拔牙后药物相关性颌骨坏死的相关风险因素：原发伤口闭合和药物暂停真的能预防 MRONJ 吗？
Osteoporos Int. 2017 Aug;28(8):2465-2473. doi: 10.1007/s00198-017-4063-7. Epub 2017 Apr 27.
4
Risk factors of osteonecrosis of the jaw after tooth extraction in osteoporotic patients on oral bisphosphonates.口服双膦酸盐的骨质疏松症患者拔牙后颌骨坏死的危险因素。
Imaging Sci Dent. 2017 Mar;47(1):45-50. doi: 10.5624/isd.2017.47.1.45. Epub 2017 Mar 21.
5
Dental extractions and bisphosphonates: the assessment, consent and management, a proposed algorithm.拔牙与双膦酸盐：评估、同意及管理，一种建议算法
Br Dent J. 2009 Jan 24;206(2):93-8. doi: 10.1038/sj.bdj.2009.5.